Security Snapshot

uniQure N.V. - COMMON STOCK (QURE) Institutional Ownership

CUSIP: N90064101

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

221

Shares (Excl. Options)

61,851,441

Price

$23.93

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / COMMON STOCK
Symbol
QURE on Nasdaq
Shares outstanding
62,278,853
Price per share
$17.92
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
61,851,441
Total reported value
$1,480,095,997
% of total 13F portfolios
0.01%
Share change
+6,308,290
Value change
-$115,090,755
Number of holders
221
Price from insider filings
$17.92
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • QURE - uniQure N.V. - COMMON STOCK is tracked under CUSIP N90064101.
  • 221 institutions reported positions in Q4 2025.
  • 8 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 221 to 54 between Q4 2025 and Q1 2026.
  • Reported value moved from $1,480,095,997 to $152,193,823.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 221 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP N90064101?
CUSIP N90064101 identifies QURE - uniQure N.V. - COMMON STOCK in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of uniQure N.V. - COMMON STOCK (QURE) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Avoro Capital Advisors LLC 9.9% +47% $143,848,500 +$59,059,750 6,150,000 +70% Avoro Capital Advisors LLC 31 Dec 2025
Aberdeen Group plc 8.5% +43% $86,759,411 +$26,613,647 5,306,386 +44% abrdn Inc. 01 Apr 2026
RTW INVESTMENTS, LP 6% -17% $86,811,096 -$16,688,905 3,711,462 -16% RTW Investments, LP 31 Dec 2025
SUSQUEHANNA SECURITIES, LLC 5.7% $82,718,384 3,536,485 G1 Execution Services, LLC 31 Dec 2025
STATE STREET CORP 5.2% $75,574,096 3,231,043 STATE STREET CORPORATION 31 Dec 2025
Nantahala Capital Management, LLC 3.8% -40% $29,546,669 -$13,394,318 2,051,852 -31% Nantahala Capital Management, LLC 30 Jun 2025
FMR LLC 2.8% -70% $31,249,037 -$77,338,527 1,743,808 -71% FMR LLC 31 Mar 2026
Vestal Point Capital, LP 0.4% -91% $13,133,250 -$202,835,750 225,000 -94% Vestal Point Capital, LP 30 Sep 2025

As of 31 Dec 2025, 221 institutional investors reported holding 61,851,441 shares of uniQure N.V. - COMMON STOCK (QURE). This represents 99% of the company’s total 62,278,853 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of uniQure N.V. - COMMON STOCK (QURE) together control 73% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FMR LLC 10% 6,240,936 +3% 0.01% $149,345,604
Avoro Capital Advisors LLC 9.9% 6,150,000 +38% 1.4% $147,169,500
RTW INVESTMENTS, LP 6% 3,711,462 -16% 0.89% $88,815,286
Aberdeen Group plc 5.9% 3,678,640 +25% 0.14% $88,029,855
STATE STREET CORP 5.2% 3,231,043 +124% 0% $77,318,859
JPMORGAN CHASE & CO 4.7% 2,934,626 +155% 0% $70,225,603
BlackRock, Inc. 3.2% 1,974,988 +37% 0% $47,261,464
TWO SIGMA INVESTMENTS, LP 2.3% 1,451,284 +62% 0.05% $34,729,226
MPM BIOIMPACT LLC 2.2% 1,381,628 3.8% $33,062,358
JENNISON ASSOCIATES LLC 2.2% 1,371,190 +37% 0.02% $32,812,576
SUSQUEHANNA INTERNATIONAL GROUP, LLP 2% 1,218,350 +440% 0.04% $29,155,116
SUVRETTA CAPITAL MANAGEMENT, LLC 2% 1,216,734 0.73% $29,116,445
GOLDMAN SACHS GROUP INC 1.9% 1,167,608 +76% 0% $27,940,859
TWO SIGMA ADVISERS, LP 1.8% 1,110,400 +171% 0.05% $26,571,872
VANGUARD GROUP INC 1.7% 1,051,379 -6.6% 0% $25,159,500
Artia Global Partners LP 1.6% 1,023,539 +55% 3.9% $24,493,288
Integral Health Asset Management, LLC 1.4% 900,000 +50% 1.1% $21,537,000
MILLENNIUM MANAGEMENT LLC 1.3% 803,605 +319% 0.01% $19,230,268
GEODE CAPITAL MANAGEMENT, LLC 1.2% 776,071 +7.5% 0% $18,578,179
Fiera Capital Corp 1.2% 768,510 0.06% $18,390,444
FRANKLIN RESOURCES INC 1.2% 746,602 -62% 0% $17,866,186
ORBIMED ADVISORS LLC 1.2% 737,400 +61% 0.38% $17,645,982
MORGAN STANLEY 1.2% 716,927 +123% 0% $17,156,063
Nantahala Capital Management, LLC 1.1% 699,298 -31% 1% $16,734,201
Logos Global Management LP 1.1% 675,000 +125% 1.1% $16,152,750

Institutional Holders of uniQure N.V. - COMMON STOCK (QURE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 9,308,518 $152,193,823 +$32,505,726 $16.35 54
2025 Q4 61,851,441 $1,480,095,997 -$115,090,755 $23.93 221
2025 Q3 55,352,343 $3,231,367,488 +$237,515,957 $58.37 218
2025 Q2 52,961,222 $738,302,097 +$50,637,556 $13.94 143
2025 Q1 49,986,625 $532,054,267 +$84,767,075 $10.60 139
2024 Q4 41,605,808 $734,372,507 +$59,578,946 $17.66 136
2024 Q3 38,874,270 $192,931,529 +$40,181,251 $4.93 129
2024 Q2 31,728,639 $141,844,153 -$3,825,259 $4.48 112
2024 Q1 32,322,300 $168,079,173 -$35,691,371 $5.20 130
2023 Q4 37,687,636 $255,220,282 -$8,276,086 $6.77 143
2023 Q3 35,800,237 $240,082,030 -$11,389,007 $6.71 160
2023 Q2 35,929,422 $411,603,802 -$102,920,571 $11.46 173
2023 Q1 41,579,108 $837,317,405 +$27,836,492 $20.14 170
2022 Q4 40,238,914 $912,094,750 -$33,364,677 $22.67 174
2022 Q3 42,072,015 $789,027,381 +$16,257,084 $18.76 155
2022 Q2 40,495,580 $754,734,025 +$52,181,297 $18.64 161
2022 Q1 37,951,511 $685,692,734 +$3,739,840 $18.07 162
2021 Q4 37,700,468 $782,152,012 -$10,555,469 $20.74 169
2021 Q3 37,029,922 $1,185,365,197 +$36,464,815 $32.01 170
2021 Q2 35,921,387 $1,106,406,897 -$14,666,760 $30.80 153
2021 Q1 36,324,502 $1,223,768,350 +$31,780,970 $33.69 153
2020 Q4 34,974,972 $1,263,910,909 -$11,650,805 $36.13 160
2020 Q3 35,272,720 $1,298,543,100 -$827,360 $36.83 157
2020 Q2 34,963,826 $1,573,348,794 -$20,279,224 $45.06 172
2020 Q1 35,310,616 $1,675,810,163 -$22,488,569 $47.45 167
2019 Q4 34,655,343 $2,483,224,906 +$183,794,307 $71.66 179
2019 Q3 32,038,308 $1,260,902,231 +$155,277,735 $39.36 155
2019 Q2 26,449,920 $2,066,161,619 +$440,721,480 $78.15 143
2019 Q1 22,704,127 $1,354,292,705 +$7,107,528 $59.65 128
2018 Q4 22,760,640 $655,512,079 -$4,279,771 $28.82 93
2018 Q3 22,572,035 $821,994,896 +$5,790,048 $36.39 98
2018 Q2 22,030,252 $832,692,000 +$220,229,387 $37.80 94
2018 Q1 16,267,232 $382,280,000 +$66,881,880 $23.50 66
2017 Q4 13,549,875 $265,453,073 +$106,494,269 $19.59 60
2017 Q3 7,666,082 $73,561,120 +$258,592 $9.60 35
2017 Q2 7,650,235 $47,354,000 +$3,032,085 $6.19 31
2017 Q1 7,213,970 $41,691,000 -$1,974,062 $5.78 37
2016 Q4 7,619,508 $42,662,000 -$3,166,022 $5.60 50
2016 Q3 7,075,534 $54,129,000 -$8,015,435 $7.65 48
2016 Q2 8,137,564 $59,960,000 -$8,779,594 $7.37 57
2016 Q1 9,135,928 $108,531,000 +$7,848,398 $11.88 56
2015 Q4 8,219,077 $135,936,000 -$884,886 $16.54 64
2015 Q3 7,929,168 $162,145,000 -$249,360 $20.45 62
2015 Q2 7,678,180 $207,309,000 +$75,445,120 $27.00 53
2015 Q1 4,924,505 $119,703,000 +$32,132,767 $24.32 40
2014 Q4 3,821,918 $56,602,200 +$6,865,008 $14.81 27
2014 Q3 3,456,020 $31,869,000 -$65,722 $9.24 26
2014 Q2 3,422,576 $46,512,000 +$44,407 $13.59 26
2014 Q1 3,341,209 $51,981,000 +$51,981,000 $15.55 24
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .